Skip to main content

Bufotenin Facts

Psychedelic; Substituted tryptamine; Serotonin 2A receptor agonist

Description

Bufotenin (5-hydroxy-N,N-dimethyltryptamine) is a naturally-occurring psychedelic of the tryptamine class. It activates serotonin receptors but barely triggers the one responsible for classic psychedelic effects, producing a body-heavy altered state rather than vivid visuals.

Subjective effects include visual distortions, euphoria, bodily heaviness, facial flushing, and brief altered states of consciousness.[1] The experience is more body-dominated than any classic psychedelic — cardiovascular pressure and physical weight come first, with genuine psychedelic content emerging only at higher doses.

Bufotenin produces no physical dependence, but the cardiovascular risk is real — it directly raises heart rate and the force of heart contractions.[2] The greatest additional danger comes from monoamine oxidase inhibitors, which block the enzyme that clears bufotenin and dramatically amplify cardiac exposure.

Dose and durationby route · individual sensitivity varies

Smoked(mg)
Threshold< 2 mgLight5 – 20 mgCommon20 – 40 mgStrong40 – 60 mgHeavy60+ mg

Starts in 0.25 – 0.5 minLasts 15 – 90 minAfter-effects 30 – 120 min

Body and dependence

Acute toxicity
Moderate
Chronic toxicity
Low
Physical dependence
None
Psychological dependence
Negligible
Withdrawal
None recorded
Compulsive redosing
Negligible

Tolerance

Builds
Rapid
Fully resets after
2 hours
Carries over to
DMT; 5-MeO-DMT; psilocybin; psilocin; LSD

Effectslikely at a common dose

Perception
Holotropic state; +32 possible, including Vestibular distortion, Spatial disorientation, Visual haze / noise
Body
Body scan awareness; +27 possible, including Nausea, Vasoconstriction, Motor control impairment
Thinking
none likely · 34 possible, including Memory suppression, Cognitive impairment, Confusion
Feeling
none likely · 9 possible, including Anxiety, Emotional lability, Dysphoria
Self
none likely · 9 possible, including Derealization, Communication suppression, Depersonalization
Time
Time alteration; +2 possible, including Temporal disorientation

Who shouldn't take it

Absolute
Cardiovascular disease; Hypertension; Cardiac arrhythmia; Pregnancy and breastfeeding; MAOI use; Tramadol use
Relative
Psychotic disorders

Combinations61 recorded

Lethal (1)
MAOIs
Dangerous (19)
MDMA, MDA; Alpha-2 adrenergic receptor antagonist; Dopamine agonists; DXM; GHB, Baclofen; GHB, GBL; Ibogaine; Ketamine, DXM, PCP; Lithium; Local anesthetics; MDMA, Amphetamines; NDRIs (Wellbutrin); NRIs; Psychedelics; Salvia, Ibogaine; SNRIs; SSRIs; Stimulants; Synthetic cannabinoids
Caution (37)
See full page: psychedex.org/substances/bufotenin
Not graded (4)
Not listed never means safe.

Seek help immediately if

Most difficulty is psychological (intense fear, panic, confusion) and passes with calm support — the signs below mean seek emergency help:

  • Very high body temperature; hot, dry skin
  • Seizures
  • Chest pain; fast or irregular heartbeat
  • Severe muscle rigidity, tremor, or twitching (possible serotonin syndrome)
  • Cold, pale, or blue fingers/toes — severe vasoconstriction (notably NBOMe / DOx)
  • Persistent vomiting; unconsciousness; uncontrollable agitation or risk of self-harm

What to do

  1. Stay calm and reassure — remind them they took a drug and the effect will pass
  2. Move to a calm, quiet, safe space with low light; reduce noise and sensory input
  3. Keep them from harm — they may act on fear or confusion; stay with them, don't leave them alone
  4. Talk them down gently; don't grab or restrain unless they're in danger
  5. For the medical signs above (overheating, seizure, chest pain, vasoconstriction, unresponsive) call emergency services
  6. If overheating, cool the body; be ready to give rescue breaths / CPR

The experience is time-limited and usually resolves with calm reassurance in a safe setting — psychological first aid, not medication. Serious physical harm is uncommon for classic psychedelics (LSD, psilocybin) but real for some potent phenethylamines (NBOMe, DOx), where hyperthermia, seizures, and vasoconstriction warrant emergency care.

988 Suicide & Crisis LifelineFireside Project: 62-FIRESIDE

Version r1 · Not medical advice

References

  1. [1]
    ^Chamakura RP (1994) Bufotenine - A Hallucinogen in Ancient Snuff Powders of South America and a Drug of Abuse on the Streets of New York City. — Forensic Science Review PMID:26270149
  2. [2]
    ^Neumann J, Schulz N, Fehse C, Azatsian K, et al. (2023) Cardiovascular effects of bufotenin on human 5-HT4 serotonin receptors in cardiac preparations of transgenic mice and in human atrial preparations. — Naunyn-Schmiedeberg's Archives of Pharmacology doi:10.1007/s00210-023-02414-8
Print version
Report an issue